IDX · ASX

Integral Diagnostics Ltd (ASX:IDX)

AU$3.03

 0.03 (1.0%)
ASX:Live
13/12/2024 04:10:53 PM
Volume Spike Short Sold <-1 over the month Recent Price upgrade Hammer Bearish HALO Small +7
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

IDX Overview

IDX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Weak

Halo Model

MQV

Weak

GARP

Weak

MQV Small

Weak

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Strong

About IDX

Website

Integral Diagnostics Ltd

Telephone

61.3.5339.0704

Address

Level 9 Suite 9.02 45 William Street Melbourne, Victoria (VIC) 3000

Description

Integral Diagnostics Ltd. engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied professionals. It operates under three core brands: Lake Imaging, South Coast Radiology, and Global Diagnostics. The company was founded in 1967 and is headquartered in North Melbourne, Australia.

IDX Price Chart

Key Stats

Market Cap

AU$713.58M

PE

32.40

EV/EBITDA

9.1

Dividends Overview

DIV Yield

2.4%

Franking

100%

Ex Dividend Date (est.)

30-Aug-24

Market Data

52 weeks range

Low 1.8 - 3.2

Trade Value (12mth)

AU$452,639.00

1 week

4.17%

1 month

-0.99%

YTD

55.44%

1 year

59.15%

All time high

5.47

Key Fundamentals

EPS 3 yr Growth

-266.90%

EBITDA Margin

19.00%

Operating Cashflow

$66m

Free Cash Flow Return

9.70%

ROIC

-8.90%

Interest Coverage

4.00

Quick Ratio

0.80

Other Data

Shares on Issue (Fully Dilluted)

234m

HALO Sector

Healthcare

Next Company Report Date

25-Aug-25

Ex Dividend Date (est.)

30-Aug-24

Next Dividend Pay Date (est.)

03-Oct-24

Reporting Currency

AUD

Short Sell (% of issue)

3.53

IDX Announcements

Latest Announcements

Date Announcements

11 December 24

CAJ: Scheme becomes Effective

×

CAJ: Scheme becomes Effective

10 December 24

AXX: IDX acquisit'n of CAJ unopposed, subject to divestiture

×

AXX: IDX acquisit'n of CAJ unopposed, subject to divestiture

10 December 24

Merger Update

×

Merger Update

10 December 24

CAJ: ACCC provides informal merger clearance

×

CAJ: ACCC provides informal merger clearance

10 December 24

CAJ: Court Approval of Scheme

×

CAJ: Court Approval of Scheme

10 December 24

Proposed issue of securities - IDX

×

Proposed issue of securities - IDX

09 December 24

Becoming a substantial holder

×

Becoming a substantial holder

09 December 24

Becoming a substantial holder from MS

×

Becoming a substantial holder from MS

09 December 24

Becoming a substantial holder from MUFG

×

Becoming a substantial holder from MUFG

06 December 24

Becoming a substantial holder

×

Becoming a substantial holder

06 December 24

Becoming a substantial holder

×

Becoming a substantial holder

04 December 24

CAJ: Merger Update

×

CAJ: Merger Update

02 December 24

CAJ: Scheme Meeting Results-Shareholders vote in favour

×

CAJ: Scheme Meeting Results-Shareholders vote in favour

29 November 24

CAJ: Merger Update

×

CAJ: Merger Update

26 November 24

CAJ: Notice of Second Court Hearing

×

CAJ: Notice of Second Court Hearing

25 November 24

Proposed merger with Capitol Health - Update

×

Proposed merger with Capitol Health - Update

25 November 24

CAJ: Merger Update

×

CAJ: Merger Update

12 November 24

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

12 November 24

Becoming a substantial holder from CGF

×

Becoming a substantial holder from CGF

07 November 24

Change of Director's Interest Notice - Toby Hall

×

Change of Director's Interest Notice - Toby Hall

01 November 24

AGM - Chair's Address and Presentation

×

AGM - Chair's Address and Presentation

01 November 24

AGM - CEO Address and Presentation

×

AGM - CEO Address and Presentation

01 November 24

Results of Annual General Meeting

×

Results of Annual General Meeting

01 November 24

Change of Director's Interest Notice - Dr Ian Kadish

×

Change of Director's Interest Notice - Dr Ian Kadish

01 November 24

Notification regarding unquoted securities - IDX

×

Notification regarding unquoted securities - IDX

IDX Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.07 0.11 -0.26 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.07 0.11 -0.26 Lock Lock Lock
     Growth % Lock Lock Lock Lock -55.2 54.2 -341.6 Lock Lock Lock
     PE X Lock Lock Lock Lock 22.5 35.9 32.4 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 10.1 10.9 9.1 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.21 0.24 0.27 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.05 0.05 0.12 Lock Lock Lock
     Growth % Lock Lock Lock Lock -35.2 11.6 12.2 Lock Lock Lock
     Yield % Lock Lock Lock Lock -1.8 1.4 4.6 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.07 0.06 0.06 Lock Lock Lock
     Growth % Lock Lock Lock Lock -43.2 -14.3 -3.3 Lock Lock Lock
     Yield % Lock Lock Lock Lock 3.0 1.9 2.4 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 100 56 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 1.52 1.60 1.29 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock -0.15 -0.44 -0.42 Lock Lock Lock
     Growth % Lock Lock Lock Lock 67.5 -200.8 4.7 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 212 233 233 Lock Lock Lock
Basic m Lock Lock Lock Lock 209 233 233 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 359 440 470 Lock Lock Lock
     Growth % Lock Lock Lock Lock 2.8 22.7 6.7 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 48 59 62 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 84 96 104 Lock Lock Lock
     Growth % Lock Lock Lock Lock -9.1 15.0 7.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 23.4 21.9 22.1 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 77 78 78 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 75 82 89 Lock Lock Lock
     Growth % Lock Lock Lock Lock -9.2 9.1 8.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 20.9 18.6 19.0 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 37 43 47 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 38 38 42 Lock Lock Lock
     Growth % Lock Lock Lock Lock -19.7 0.1 8.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 10.7 8.7 8.9 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 23 31 -57 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 8 6 4 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 15 25 -61 Lock Lock Lock
     Growth % Lock Lock Lock Lock -53.3 71.5 -342.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock 4.1 5.7 -12.9 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 37 67 66 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 28 44 24 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -56 -129 -28 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 81 -28 -29 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 9 23 42 Lock Lock Lock
     Growth % Lock Lock Lock Lock -81.1 148.1 82.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.0 0.1 0.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 31 35 23 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 123 34 42 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 783 824 744 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 324 348 342 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 218 331 315 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 436 451 443 Lock Lock Lock
Equity $m Lock Lock Lock Lock 347 373 302 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 671 721 643 Lock Lock Lock
     Growth % Lock Lock Lock Lock 22.9 7.5 -10.8 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 1.9 3.0 -8.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 4.2 6.7 -20.1 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 6.1 5.4 6.0 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 2.4 3.6 -8.9 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 6.1 9.6 9.7 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock 7.2 4.5 4.0 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 2.9 4.0 3.5 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 62.7 88.8 104.5 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 2.0 0.8 0.9 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.9 0.7 0.8 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 77.9 54.0 56.7 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 46.0 80.4 75.9 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 17.9 18.3 18.4 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 252.4 220.9 209.1 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 4.6 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 2.4 2.4 2.2 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.5 0.5 0.6 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.5 0.5 0.6 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 6.3 7.0 -12.2 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 2.9 3.8 -7.7 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 35.0 18.1 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 1.9 3.0 -8.2 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 2.3 2.2 2.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 4.2 6.7 -20.1 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock -0.3 44.2 122.3 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -0.0 3.0 -24.6 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 1.4 1.7 1.7 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 20.4 20.0 19.8 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 21.9 21.6 21.6 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 8.9 10.1 10.3 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 13.0 11.5 11.3 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

30-Aug-24

DIV Yield

2.4%

Franking Level

100%

DPSg

-3.30%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

3.53%

Value ($M)

24

Prior Change

-1.20%

7 Day Change

-1.20%

1 Month Change

-1.50%

3 Month Change

-1.60%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

IDX Shortsell

Frequently Asked Questions

The current share price of Integral Diagnostics Ltd (IDX:ASX) is AU$3.03.
The 52-week high share price for Integral Diagnostics Ltd (IDX:ASX) is AU$3.20.
The 52-week low share price for Integral Diagnostics Ltd (IDX:ASX)? is AU$1.80.
The current TTM dividend payout for Integral Diagnostics Ltd (IDX:ASX) is 2.40.
The last dividend payment of Integral Diagnostics Ltd (IDX:ASX) is AU$0.03.
Integral Diagnostics Ltd (IDX:ASX) has a franking level of 100.0%.
Integral Diagnostics Ltd (IDX:ASX) is classified in the Healthcare.
The current P/E ratio for Integral Diagnostics Ltd (IDX:ASX) is 32.40.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.